Reply: Strengths and limitations of using health administrative databases to understand the impact of Philips Respironics recall on long-term adverse health outcomes

Tetyana Kendzerska^{1

2

3

4}, Robert Talarico^{5

2}, Sachin R Pendharkar^{6

7

8}, Marcus Povitz⁶

Affiliations

¹ The Ottawa Hospital Research Institute, Ottawa, ON, Canada tkendzerska@toh.ca.
² ICES, Ottawa, ON, Canada.
³ Department of Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
⁴ School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.
⁵ The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
⁶ Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
⁷ Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
⁸ O'Brien Institute for Public Health, University of Calgary, Calgary, AB, Canada.

PMID: 40049736
DOI: 10.1183/13993003.02035-2024

Comment

Reply: Strengths and limitations of using health administrative databases to understand the impact of Philips Respironics recall on long-term adverse health outcomes

Tetyana Kendzerska et al. Eur Respir J. 2025.

. 2025 Mar 6;65(3):2402035.

doi: 10.1183/13993003.02035-2024. Print 2025 Mar.

Authors

Tetyana Kendzerska^{1

2

3

4}, Robert Talarico^{5

2}, Sachin R Pendharkar^{6

7

8}, Marcus Povitz⁶

Affiliations

¹ The Ottawa Hospital Research Institute, Ottawa, ON, Canada tkendzerska@toh.ca.
² ICES, Ottawa, ON, Canada.
³ Department of Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
⁴ School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.
⁵ The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
⁶ Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
⁷ Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
⁸ O'Brien Institute for Public Health, University of Calgary, Calgary, AB, Canada.

PMID: 40049736
DOI: 10.1183/13993003.02035-2024

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: All authors declare they have no potential conflict of interest. T. Kendzerska is supported by the PSI (Physicians’ Services Incorporated) foundation. Outside of the submitted work, S.R. Pendharkar has received honoraria from Jazz Pharmaceuticals, Paladin Labs and the International Centre for Professional Development in Health and Medicine for participation in educational activities and grant funding from Jazz Pharmaceuticals. Outside of the submitted work, M. Povitz has received a fellowship grant from Paladin Labs and contract research from Jazz Pharmaceuticals.

Comment on

Association between a recalled positive airway pressure device and incident cancer: a population-based study.
Kendzerska T, Pendharkar SR, Talarico R, Blades K, Mackenzie C, Gershon AS, Ayas N, Kaminska M, Fenton M, McBrien KA, Hawken S, Ratycz D, Lishchenko V, Owens RL, Povitz M. Kendzerska T, et al. Eur Respir J. 2024 Nov 7;64(5):2400560. doi: 10.1183/13993003.00560-2024. Print 2024 Nov. Eur Respir J. 2024. PMID: 39147408

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reply: Strengths and limitations of using health administrative databases to understand the impact of Philips Respironics recall on long-term adverse health outcomes

Affiliations

Reply: Strengths and limitations of using health administrative databases to understand the impact of Philips Respironics recall on long-term adverse health outcomes

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

LinkOut - more resources

Full Text Sources